Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
It marks the second COVID-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to the state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.
Prior to the approvals, both vaccines have already been used in China's vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release.
The approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained, Sinovac said.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Huawei’s Upcoming Tri-Fold Smartphone Tipped to Carry a Hefty Price Tag at Launch US Navy's Newest Air-To-Air Missile Could Tilt Balance In South China Sea China's ''Most Handsome'' Shaolin Monk Dies In Car Accident At 21 Nurse Raped, Killed On Way Home, Body Found 9 Days Later In UP "Don't Expect Anything From Me": Kolkata Hospital's New Principal Loses Cool Rahul Gandhi's Seat At Red Fort Triggers Fresh Congress Attack On BJP 6.3 Magnitude Earthquake Hits Taiwan: Weather Agency Relationship With India Remains One Of Great Importance: Pentagon Kolkata Rape: Top Medical Body Announces Withdrawal Of Services On Aug 17 Track Latest News Live on NDTV.com and get news updates from India and around the world.